INTRODUCTION
Since its inception in the 80's, more than 400 papers have relied on the minimal model (MM) of glucose kinetics [2] to measure metabolic indexes such as glucose effectiveness (S G ) and insulin sensitivity (S I ) in humans, in both normal and physiopathological conditions.
The MM is identified from plasma glucose and insulin concentrations measured in the individual during an intravenous glucose tolerance test (IVGTT). The standard sampling schedule is a frequent one (FSS) and consists of about 30 points collected over 4 hours. In order to reduce the experiment complexity and economic costs and to facilitate the MM use in large clinical/epidemiological studies, reduced sampling schedules (RSS), consisting of 13-14 samples, have been proposed for normal subjects [18] . Unfortunately, by using RSS, the precision of S G and S I estimates deteriorates and often becomes poor. This difficulty was recently pointed out by Vicini and Cobelli [21] who proposed, in alternative to the standard nonlinear least squares (NLS) model identification strategy, the use of a "population" approach, namely the iterative two-stage (ITS) [19] . They showed on 16 normal (or healthy) subjects that ITS allows, in presence of RSS, a significant improvement (with respect to NLS) of the precision of parameter estimates in the single individual.
However, a first intrinsic limitation of ITS is given by the fact that, being a population approach, it requires a sufficiently large (e.g. tens of subjects) and homogenous IVGTT data base. In addition, with ITS any variation in IVGTT data set (e.g., addition of a new subject or elimination of an outlier) implies to recalculate the parameters estimates for all the subjects. Other critical points of ITS concern statistical/theoretical issues.
For instance, ITS assumes that model parameters are normally distributed within the population and provides confidence intervals which are, by construction, symmetric with respect to point estimates (e.g. mean ± two standard deviations) and thus not necessarily realistic (e.g. they can include negative values). The availability of reliable confidence intervals, can be crucial in those investigations in which the estimated physiological pa-1 rameters have to be used, possibly together with other clinical, metabolic and genetic variables, e.g. for characterizing a population or for performing clustering, classification, regression or risk analysis [10, 6, 11] .
In this paper, we approach the problem of identifying MM in presence of RSS by developing a Bayesian parameter estimation method implemented by Markov chain Monte Carlo (MCMC) [9, 7] . The method works on a single individual basis and thus does not impose the requirements of population methods like ITS. By applying the method to the same IVGTT data set of 16 normal subjects analyzed in [21] , we show that in passing from FSS to RSS only a limited deterioration in parameter estimates precision occurs and that, in nearly all the subjects, point parameter estimates do not significantly change. In addition, using the Bayesian method credible confidence intervals (e.g. excluding negative values) are obtained. In nearly all the subjects the RSS confidence intervals are very close to the FSS ones, suggesting that the Bayesian methodology can compensate for the loss of information due to sampling reduction. The new method also performs better in terms of both accuracy and precision of estimates than ITS population method (and thus NLS).
MATERIALS AND METHODS

Data base
The IVGTT data have been already described in [20] to which we refer the reader for details. Briefly, in each of the 16 normal adults, a glucose bolus (between 300 and 330 mg/kg body wt) was administered at time 0. Plasma glucose and insulin concentrations were measured for 4h with a FSS of 30 samples, from which a RSS of only 14 samples (bold characters) was extracted (0, 2, 3, 4, 5, 8, 10, 12, 14, 16, 18, 20, 24, 28, 32, 40, 45, 50, 60, 70, 80, 90, 100, 110, 120, 140, 160, 180, 210, 240 mins). The adopted RSS is based on the previous studies presented in the literature on optimal sampling schedules for MM identification [4, 17] . Measurement errors of glucose concentrations are assumed to be additive, independent, Gaussian, with zero mean and a 2% coefficient of variation (CV).
Minimal model of glucose kinetics
The equations of the MM of glucose kinetics during an IVGTT [2] can be written as follows [15] :
where G(t) (mg/dl ) and I(t) (µU/ml ) are plasma glucose and insulin concentrations respectively, with G b and I b representing their baseline values, X(t) (min
) is glucose effectiveness, S I (min
) is an insulin action parameter, G 0 is the value of G extrapolated at time 0, with
) and D (mg·kg 
Minimal model identification: NLS and ITS
MM parameter estimation consists in determining the unknown model parameter vec-
T from plasma glucose concentration measurements, by assuming plasma insulin concentration I(t) as a known input (from G 0 one obtains V trough the above relation, being D and G b known). Plasma glucose concentration measurement at time t i , i.e. G(t i ), can be described as
where h(t i , θ) is a function of θ defined from (1) and (2), y i is the measurement, and v i is the measurement error. Note that all model parameters are a priori uniquely identifiable once I(t) in (2) is assumed to be known.
Single individual methods
The most widely used approach to estimate θ from (3) is NLS:
where w i are weights (generally chosen as the inverse of the variance of the measurement error). Note that, if the measurement errors are independent, Gaussian stochastic variables with zero mean and variance equal to 1/w i ,θ provided by (4) represents also the maximum likelihood estimate.
Precision of NLS estimates, expressed by their standard deviation (SD), is obtained from the square root of the diagonal elements of the inverse of the Fisher information matrix [3] . From this matrix, a symmetric 95% confidence interval can be obtained aŝ
Population methods
When the data for the MM identification are available in a population of M homogeneous subjects, the so-called population methods, such as ITS [21] , can be applied. Briefly, the In principle, other more sophisticated population approaches, such as nonlinear mixed effects models [5] or hierarchical Bayesian models [22] , could be used to cope with IVGTT MM identification in presence of RSS. A detailed discussion comparing ITS and other population approaches is reported in [21] . However, the main drawback of all population approaches is that they appear oversized for our specific problem. In fact: i) they require to have IVGTT data in a homogeneous and quite large group (say tens of subjects); ii)
any variation in the data (e.g. addition of a new subject or elimination of an outlier)
implies the recalculation of MM parameter estimates in all the M subjects.
Minimal model identification: a Bayesian approach
The key quantity in Bayesian parameter estimation is the a posteriori probability density function f θ|y (θ | y) (also called, for brevity, the posterior) of the unknown model parameters ("θ | y" reads "θ given y") [8] . From this function, that provides a complete description of the shape of the estimate uncertainty, the 95% confidence intervals can be derived, e.g. as the interval between the 2.5 and the 97.5 percentile of the distribution.
Notably, these intervals are allowed to be asymmetric with respect to any of the possible point estimates obtainable in a Bayesian framework, such as the median, the mode or the mean.
The a posteriori probability density function of the parameter vector θ can be obtained from the Bayes theorem as:
In the right hand side of (5), f y (y) does not depend on θ and can be considered as a scale factor, f y|θ (y | θ) is the likelihood function of the data (obtainable from (3) by exploiting the knowledge of measurement error statistics), and f θ (θ) is a given function (also called the a priori density function of θ or simply the prior) which formalizes in statistical terms the a priori available knowledge on the unknown model parameters. The problem of
The choice of the prior A first a priori knowledge which can be incorporated within f θ (θ) concerns nonnegativity of all MM parameters. A natural choice is thus the adoption of a log-normal (LN) distri-
Additional a priori knowledge, likely useful to overcome possible numerical identifiability problems [13] in presence of RSS, is obtainable by exploiting the sample distributions of MM parameters estimated by NLS in separate group of subjects undertaken to IVGTT with FSS. This analysis was performed in an independent study on 50 normal subjects (not including the 16 subjects considered in this paper) and showed that estimates are approximately log-normally distributed. Therefore, we have assumed:
where the values of mean and variance were determined by fitting the sample distribution of θ in the 50 normal subjects. These values were also found to be stable with respect to changes of the training set, such as the random extraction of subsets of the 50 subjects.
Implementation by MCMC
Obtaining f θ|y (θ | y) from (5) is a task analytically intractable because of the complex relationships between parameters and data. Therefore an MCMC simulation strategy was used [9, 12] . Details are give in the Appendix.
RESULTS
Here we discuss the results obtained on the 16 IVGTT data sets. First, we consider the FSS situation which represents the reference and discuss NLS and Bayesian estimates.
Then, we assess the information loss that occurs in a single subject with the Bayesian estimator when RSS instead of FSS is adopted. Subsequently, we compare the Bayesian estimator with both ITS and NLS estimator for RSS. Finally, we discuss the dependence of the estimates on the prior f θ (θ).
For allowing a direct comparison with the results of [21] , we will report the estimates of V in place of those of G 0 . Focus will be on the two most clinically important MM parameters, i.e. S G and S I . subjects by using the Bayesian estimator with FSS (already shown in Fig. 1 ) and RSS. The pictures also include the a posteriori distribution of S G and S I in two representative subjects (#1 and #18). The comparison demonstrates that, in general, the use of the Bayesian estimator allows a reduction of sampling schedule without significantly affecting the accuracy and precision of MM identification. In fact, the a posteriori probability density functions, and thus the confidence intervals, of RSS estimates are generally very close to the FSS ones (see also the posterior of S I in Fig. 2 in #1 and #18 ). Even in those rare cases in which some differences between the two estimates is present (see Fig. 2 in #18) , the confidence intervals derived for FSS and RSS lie in relatively near regions. The only exception concerns p 2 in #16, but this is not surprising since p 2 is known to be often a poorly identifiable parameter [14] .
Frequent sampling schedule
Reduced vs frequent sampling schedule
As far as point estimates are concerned, they are in general very similar. In fact, percent differences between RSS and FSS (mean and the 10, 90 percentile, in brackets) 
Reduced sampling schedule: comparison with NLS and ITS
The results obtained in presence of RSS with NLS, ITS and Bayesian estimators are summarized in Fig. 3 for S G and S I (ITS estimates are taken from [21] ). As already highlighted in [21] , in presence of RSS NLS is not suitable for MM identification because it leads to unacceptably large CV. For example, in one subject (#11) CV higher than 500% is obtained for S I , i.e., in this case MM is a posteriori non identifiable. In 10 out of 16 subjects, NLS obtains noncredible confidence intervals (with negative portions much larger than in Fig. 1 ). As shown in Fig. 3 , ITS offers a first improvement, by drastically reducing the width of the confidence intervals, albeit negative portions are still possible Notably, point estimates provided by the three methods are, in general, quite similar and only in few cases a significant difference can be detected, as for #16. In summary, percent differences between NLS and Bayesian point estimates (mean and the 10, 90
percentile, in brackets) are:
V , respectively, whereas percent differences between precision CV are 351 (18, 824) , 348 (4, 709) , 493 (34,1101), 175 (7, 385 
Sensitivity to the choice of the prior distribution
The results reported so far were obtained by using the prior information model described Another interesting issue is to assess the role of a priori information, i.e. to understand how important is to specify an informative distribution. To provide an answer to this question, we have recalculated RSS estimates by MCMC without supplying a priori information, i.e. f θ (θ) is uniform, so that the a posteriori distribution coincides with the likelihood (which in turn is a function of the residual weighted sum of squares of NLS).
In Fig. 4 Confidence intervals are equal or larger than those obtained with the log-normal prior.
This demonstrates that a priori information plays a role in improving the performance of the Bayesian estimator. Moreover, since even using the noninformative prior brings in most cases to estimates much more precise than those obtained by NLS (e.g. compare #17 Fig. 4 with Fig. 3 ), we can conclude that the MCMC simulation strategy avoids the numerical identifiability problems often present with NLS estimates.
CONCLUSIONS
The possibility of reducing the number of samples in MM identification is appealing for obvious economical and ethical reasons and, thus, can have an important impact in clinical practice, especially in large scale studies. Unfortunately, standard NLS is usually unsuccessful in dealing with RSS due to unacceptable deterioration of the quality of estimates. Recently, population parameter estimation methods have been proposed to cope with RSS MM identification. However, population methods are not without problems.
For instance, ITS (used in [21] ), assumes that the model parameters have a gaussian probability distribution within the population, with the consequence that confidence intervals (symmetric by construction) are often not realistic (e.g. include negative values).
In addition, population methods are in general difficult to be implemented, since the data base must consist of a sufficiently large number of homogenous subjects and any change of it (e.g. removal of an outlier) requires to repeat model identification in all subjects.
In this paper we have shown that RSS MM identification can be successfully approached by a new MCMC Bayesian estimation method which works well not only in terms of population values but also at the single individual level. On a data base of 16 normal subjects, the new method was shown to provide accurate and precise MM parameter estimates (i.e. no bias with respect to FSS and acceptable CV). Notably, results are not sensitive to small changes of the probability density function chosen to express a priori knowledge. In our paper we chose a log-normal distribution obtained by fitting an independent data base of MM parameters. In addition of working reliably at the single subject level, an additional advantage of MCMC over ITS is that it provides the a posteriori probability distribution of the parameter estimates from which credible confidence intervals can be determined (e.g. asymmetric and in the range of non negative values).
This can be crucial in investigations where MM parameters are used, in conjunction with other indexes (physiological, clinical, metabolic, genetic), in statistical analyses such as characterization of a (sub)population, clustering, classification, regression, risk analysis, and so on (see [10, 6, 11] ). To better grasp the importance of having a credible measure of estimates uncertainty, let's discuss more in detail three situations. a measure of the credibility of the chosen class. The third example concerns regression [10] and risk analysis [6, 11] where, using a Bayesian framework, the uncertainty of MM parameter estimates can be propagated into the predicted outcome variables.
The proposed methodology to cope with RSS MM identification has been developed and applied in normal subjects undertaken to IVGTT, for which a validated reduced schedule was available [4, 18] . Given the encouraging results, a natural extension to pathological subjects, e.g. insulin resistant or diabetic subjects, is of obvious importance.
However, this extension is not simple since two prerequisite steps are needed. First, since there is no evidence that RSS developed in [4, 18] for normal subjects is also appropriate in pathological conditions, there is the need to develop a "pathology" specific RSS. This requires exploiting a large "pathology" FSS data base. Second, available databases of MM parameters need to exploited to build a "pathology" specific probabilistic model of prior knowledge. In fact, the prior distribution f θ (θ) developed in Sec. 2.4 is only appropriate for normal subjects. For insulin resistant subjects, for instance, a starting point could be the prior proposed in [15] to cope with numerical identifiability problems which can 16 sometimes affect MM identification even in presence of FSS.
